Rocky Mountain Cancer Centers LLP

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Metastatic breast cancer2 trials
• Colorectal cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Melanoma1 trial

Phase

• Phase 34 trials
• Phase 1/21 trial
• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting4 trials
• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Pfizer4 trials
• Seagen, a wholly owned subsidiary of Pfizer3 trials

Running trials

• Recruiting

  Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

  NCT07392892· Phase 2/3· Pfizer· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  NCT07144280· Phase 3· Pfizer· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  NCT07062965· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

  NCT06966453· Phase 1/2· Pfizer· Source

• Active, not recruiting

  A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

  NCT06012435· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source

• Recruiting

  A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

  NCT05253651· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting

Closed trials

• Completed

  Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

  NCT04609566· Phase 2· Seagen, a wholly owned subsidiary of Pfizer· Source